Home
Conditions
Lymphoma, Large B-Cell, Diffuse

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma

NCT00144755

Conditions: Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Université de Gent Ghent, Belgium

Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium

Polyclinique Bordeaux Nord Bordeaux, France

Hôpital Henri Mondor Créteil, France

View all 14 locations

View Trial Details

Completed

Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma

NCT00169195

Conditions: Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Hôpital Henri Mondor Créteil, France

Service d'Hématologie Clinique - CHU Le Bocage Dijon, France

Service des Maladies du Sang - CHRU de Lille Lille, France

Centre Léon Bérard Lyon, France

View Trial Details

Completed

ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma

NCT00144807

Conditions: Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Groupe d'Etude des Lymphomes de l'adulte Mont-Godinne, Belgium

Polyclinique Bordeaux Nord Bordeaux, France

Hôpital Henri Mondor Créteil, France

Hématologie CHU de Lille Lille, France

View all 13 locations

View Trial Details

Completed

Methoxyamine and Fludarabine Phosphate in Treating Patients With Relapsed or Refractory Hematologic Malignancies

NCT01658319

Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +85 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia

NCT02520895

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +22 more
Locations: Service d'Hématologie Clinique, Centre Hospitalier Lyon Sud Pierre-Bénite, France

View Trial Details

Completed

Dose Monitoring of Busulfan and Combination Chemotherapy in Hodgkin or Non-Hodgkin Lymphoma Undergoing Stem Cell Transplant

NCT01959477

Conditions: Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, +202 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

Combination Chemotherapy With or Without Total-Body Irradiation Followed By Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma

NCT00559104

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations: Good Samaritan Regional Medical Center Phoenix, Arizona, United States

City of Hope National Medical Center--Main Campus Duarte, California, United States

View Trial Details

Completed

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma

NCT01014208

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: GSK Investigational Site Sacramento, California, United States

GSK Investigational Site New Haven, Connecticut, United States

GSK Investigational Site Chicago, Illinois, United States

GSK Investigational Site Chicago, Illinois, United States

View all 173 locations

View Trial Details

Completed

Ofatumumab in Patients With Relapsed/Progressive Diffused Large B-Cell Lymphoma (DLBCL) Ineligible for or Relapse/Progression After Transplant

NCT00622388

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: GSK Investigational Site London, United Kingdom

View Trial Details

Completed

Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease

NCT00003414

Conditions: Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +36 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Lymphoma, Large B-Cell, Diffuse

Lymphoma, Large B-Cell, Diffuse trial results

Related conditions